[Hyaline membrane disease. Immunofluorescent study. The role of complement].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001344:Autopsy; D001706:Biopsy; D001996:Bronchopneumonia / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006819:Hyaline Membrane Disease / Q000209:etiology / Q000276:immunology*; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007231:Infant, Newborn; D008168:Lung / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D018184:Paramyxoviridae Infections / Q000276:immunology; D011663:Pulmonary Surfactants
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D011663:Pulmonary Surfactants; D003165:Complement System Proteins
Maladie des membranes hyalines. Etude en immunofluorescence. Rôle du complément